7-129203443-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_005631.5(SMO):āc.391A>Gā(p.Met131Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000127 in 1,570,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005631.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMO | NM_005631.5 | c.391A>G | p.Met131Val | missense_variant | 2/12 | ENST00000249373.8 | NP_005622.1 | |
SMO | XM_047420759.1 | c.1A>G | p.Met1? | start_lost | 3/13 | XP_047276715.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMO | ENST00000249373.8 | c.391A>G | p.Met131Val | missense_variant | 2/12 | 1 | NM_005631.5 | ENSP00000249373.3 | ||
SMO | ENST00000655644.1 | n.*255A>G | non_coding_transcript_exon_variant | 3/12 | ENSP00000499377.1 | |||||
SMO | ENST00000655644.1 | n.*255A>G | 3_prime_UTR_variant | 3/12 | ENSP00000499377.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32
GnomAD4 exome AF: 7.05e-7 AC: 1AN: 1418758Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 701876
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74350
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.391A>G (p.M131V) alteration is located in exon 2 (coding exon 2) of the SMO gene. This alteration results from a A to G substitution at nucleotide position 391, causing the methionine (M) at amino acid position 131 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at